Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study

Michele Fornaro, Michael J. McCarthy, Domenico De Berardis, Concetta De Pasquale, Matteo Martino, Colicchio, Cattanéo, Paolo D’Angelo, Pantaleo Fornaro, Tabaton

Neuropsychiatric Disease and Treatment · 2013 · 67 citations · 52 references

DOIFull text

Open access

Abstract

Agomelatine 25 mg/day was an effective and well-tolerated adjunct to valproate/lithium for acute depression in BD-II, suggesting the need for confirmation by future double blind, controlled clinical trials.

References

52